These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15879680)

  • 41. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [D-Pen2-D-Pen5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse produces antinociception through medication of spinal GABA receptors.
    Holmes BB; Fujimoto JM
    Pharmacol Biochem Behav; 1994 Nov; 49(3):675-82. PubMed ID: 7862723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide.
    Narita M; Tseng LF
    Eur J Pharmacol; 1995 Sep; 284(1-2):185-9. PubMed ID: 8549623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression.
    Gogas KR; Levine JD; Basbaum AI
    J Pharmacol Exp Ther; 1996 Feb; 276(2):801-9. PubMed ID: 8632353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
    Kamei J; Saitoh A; Ohsawa M; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Mar; 276(1-2):131-5. PubMed ID: 7781682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF
    Jpn J Pharmacol; 2002 Jul; 89(3):216-20. PubMed ID: 12184724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the antinociceptive effects of TRK-820 in the rat.
    Endoh T; Tajima A; Suzuki T; Kamei J; Narita M; Tseng L; Nagase H
    Eur J Pharmacol; 2000 Jan; 387(2):133-40. PubMed ID: 10650153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy.
    Fairbanks CA; Stone LS; Kitto KF; Nguyen HO; Posthumus IJ; Wilcox GL
    J Pharmacol Exp Ther; 2002 Jan; 300(1):282-90. PubMed ID: 11752127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats.
    Maguire DR; France CP
    Behav Pharmacol; 2016 Feb; 27(1):69-72. PubMed ID: 26292184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.
    Ocaña M; Baeyens JM
    Br J Pharmacol; 1993 Nov; 110(3):1049-54. PubMed ID: 7905339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.
    Minervini V; Lu HY; Padarti J; Osteicoechea DC; France CP
    Psychopharmacology (Berl); 2018 Aug; 235(8):2245-2256. PubMed ID: 29785554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice.
    Kamei J; Kawashima N; Narita M; Suzuki T; Misawa M; Kasuya Y
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):318-21. PubMed ID: 7862839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
    Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disparate spinal and supraspinal opioid antinociceptive responses in beta-endorphin-deficient mutant mice.
    Mogil JS; Grisel JE; Hayward MD; Bales JR; Rubinstein M; Belknap JK; Low MJ
    Neuroscience; 2000; 101(3):709-17. PubMed ID: 11113319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.